LLMO, AEO, and GEO: What Pharma & Life Sciences Teams Need to Know About AI Search Visibility

LLMO, AEO, and GEO: What Pharma & Life Sciences Teams Need to Know About AI Search Visibility
PUBLISHED
May 29, 2026
AUTHOR
Svitlana Denysenko
CATEGORY
Content Development & Strategy, AI & Data Analytics

Here’s what’s unfolding on the optimization battlefield. SERPs are flooded with AI slop, making accurate ranking challenging. AI Overviews are stealing clicks from brands, and Google is losing its status as the knowledge disseminator, as more users turn to LLMs for answers.

To make sure content doesn’t get lost or worse, get twisted into misinformation, you need to optimize for LLMs. Viseven team will show you how to do it, specifically for life sciences.

What Is LLMO, AEO, and GEO?

Effective optimization for AI search requires a combination of AEO, GEO, and LLMO. Together, they help AI systems understand your content, mention your brand, and accurately represent your expertise.

Answer Engine Optimization (AEO)

AEO is the practice of structuring content, so that AI search engines and traditional search engines select it as the best answer to a query. When someone asks Google a question and receives a featured snippet or an AI overview, AEO is what determines whose content gets quoted.

Answer Engine Optimization (AEO)

Generative Engine Optimization (GEO)

GEO targets the real-time retrieval moment in generative search tools such as ChatGPT and Perplexity. As more HCPs turn to AI-powered platforms for quick answers, GEO helps brands increase their visibility in AI-driven search results and improve the likelihood of being cited or mentioned when relevant questions are asked.

Want to dive deeper into GEO? We’ve got a full article on the best GEO practices for pharma.

Large Language Model Optimization (LLMO)

LLMO is the practice of shaping how a brand, product, or organization is represented in that training data. Because you cannot submit content directly to a model, you need to act implicitly, earning mentions in authoritative sources, like on Medscape, BMJ, or PubMed. The model considers external resources as more credible and less biased than what you say about yourself.

Large Language Model Optimization (LLMO) for pharma

Medical misinformation also becomes part of what the model “knows,” and corrections require changing what the broader web says and waiting for the next training cycle to incorporate it.

In short, AEO helps AI systems understand and retrieve your content as a direct answer to user questions. GEO increases the likelihood that your brand and expertise is cited or mentioned in AI-generated responses, while LLMO shapes the model’s baseline understanding of who you are.

What Is Changing for Pharma & Life Sciences

Coming up with one or two keywords, clicking through multiple articles, and piecing together information to find an answer now feels archaic.

Queries have grown longer, more specific, and more context-driven. Instead of searching “diabetes medication,” someone today might ask “what are the differences between GLP-1 therapy and insulin for type 2 diabetes in older adults?”

AI tools handle conversational search by selecting, summarizing, and sometimes quoting sources. What does it mean for pharma?

How you present content is just as important as the content itself

AI search engines are creating a new generation of patients who expect to play a more active role in healthcare decisions. AI assistants give them immediate access to explanations tailored to their level of understanding. A patient can ask for a clinical study to be explained “as if to a 12-year-old” and continue probing until they feel they understand the subject.

They turn to AI for quick and structured answers. If your content is not written to be retrieved easily, a competitor, medical misinformation, or AI hallucination will fill that gap.

Combating misinformation has never been more critical

Historically, misinformation could often be countered by increasing the visibility of credible content. As more authoritative articles were published, misleading information was pushed further down the search results. At the same time, users tended to click through sources and assess their credibility for themselves.

Today, search engines and AI assistants may incorporate information from virtually any source they consider relevant and well-structured. Users increasingly consume synthesized answers rather than reviewing multiple sources themselves. This leads to the situation when inaccurate information influences how customers perceive your brand, treatment, or therapeutic area, even before they reach your official content.

Once people encounter misinformation, they may develop an anchoring bias. This cognitive bias occurs when individuals place disproportionate weight on the first information they receive and become less likely to revise their views, even when presented with more accurate evidence later.

Different audiences search differently

A pharma content strategy needs to account for at least three distinct search behaviors. Patients and caregivers tend to search by symptom, condition, and outcome. Meanwhile, HCPs search by clinical category, guideline alignment, and treatment comparison.

Importantly, optimizing for these audiences no longer means creating separate keyword lists for every segment. Modern AI-powered search systems can break a user’s query into multiple sub-queries and synthesize information from various sources to generate a comprehensive answer.

SEO, GEO, AEO, LLMO for pharma

Content teams need to anticipate the questions their audiences ask as well as the follow-up questions that arise. The more completely your content addresses a user’s information need, the more likely AI systems are to recognize it as a valuable source and incorporate it into responses. — Marta Fetsatchyn, SEO/GEO Senior Specialist at Viseven

Practical Steps for Pharma Teams to Adapt

The following steps address all three optimization layers.

Start with passage-level writing

Every paragraph should function as a self-contained, citable unit. If an AI system reads a single paragraph in isolation, that paragraph should make complete sense and deliver a clear statement. Long narrative sections without breaks are invisible to AI retrieval systems, because they lack the structural signals that retrieval algorithms depend on to identify, chunk, and rank relevant content.

For longer articles, consider including a TL;DR (Too Long; Didn’t Read) section near the beginning. A concise summary helps artificial intelligence (and human readers) quickly understand the key takeaways.

Apply the BLUF approach

BLUF, or “Bottom Line Up Front,” is a military communication principle designed to surface the most important information immediately, especially in high-stakes contexts.

In life sciences, when key messages are buried, patients may miss critical health information, and AI systems may fail to retrieve credible evidence, instead surfacing better-structured but less reliable content.

For every major heading or topic, write a 40-to-60-word direct answer immediately below it. For clinical or regulatory content, this means stating the key claim, guideline reference, or comparison outcome up front, then following with supporting context, study data, and nuance.

Implement schema markup immediately

Fewer than 13% of websites use structured data. In pharma content, this represents a significant uncontested advantage. Applying the FAQPage schema to patient education pages, treatment comparison pages, and condition overview pages can increase citation rates in AI Overviews and generative search experiences by more than 3.2x.

FAQPage schema

Article schema that includes author names can further strengthen signals of expertise and credibility. Where appropriate, consider linking authors to professional profiles, such as LinkedIn pages, just as we have done in this article.

This provides additional context about the author’s experience, professional network, and industry recognition and therefore helps AI systems associate the content with a real subject-matter expert.

Maintain a visible update cadence

Recency is an important signal for AI systems when evaluating and selecting sources. This is especially relevant in life sciences, where ongoing research and development continuously generate new evidence that can refine or even contradict previous understanding. Marta notes:

AI search systems favor content that is actively maintained and regularly updated. Building a review cycle into content operations and making update dates visible on published pages is a low-hanging fruit for getting cited by AI engines.

Cite authoritative sources or give proprietary data

As AI-generated content proliferates across the web, much of what is published today is a reformulation of existing knowledge. This creates a risk of information loops, where models repeatedly encounter the same ideas and conclusions. Original research helps break that cycle, because it introduces new facts into the ecosystem and get AI see them as a valuable source when generating answers.

Claims backed by primary research and recognized industry reports earn more citations from AI answer engines than generic statements. When you publish proprietary data, you feed AI systems what they are hungry for, which is new information.

Proprietary data signals expertise and authority. It demonstrates that the organization is actively generating evidence through clinical trials, real-world studies, or other research initiatives, making it a more credible source of information.

Audit what AI models currently believe about your brand

Query ChatGPT, Gemini, Claude, and Perplexity with questions like “what does [your company] do?”, “what are the approved indications for [your product]?”, and “what are the most common criticisms of [your therapy]?”

Audit what AI models currently believe about your brand

If the model gets something wrong, that gap reveals where your LLM optimization efforts should focus. Publish accurate information across trusted third-party sources, strengthen your presence on relevant knowledge platforms such as Wikipedia, and reinforce key messages through multiple content formats, including interviews, digital opinion leader (DOL) posts, and blog articles.

Marta adds:

To ensure AI understands your content correctly, ask it to summarize the content or extract the key takeaways. This allows you to check whether you’re communicating in a language AI can easily understand and reproduce.

Use the language of uncertainty only when necessary

AI models often prefer definitive statements because they are easier to interpret and cite. In life sciences, however, phrases such as “may help,” “is associated with,” or “can reduce the risk of” are frequently necessary to accurately reflect the evidence.

For example, changing “Regular exercise may help keep you healthy by lowering your risk of several types of cancer” to “Regular exercise keeps you healthy by lowering your risk of cancer” removes important scientific nuance and overstates the evidence.

Minimize figurative language

Complex metaphors and idioms can make it harder for AI systems to interpret your content accurately. While nuance, storytelling, and figurative language make writing more human, they should be used selectively.

When a phrase requires interpretation, the model may miss the intended message or assign less weight to it. As a result, content that communicates ideas unambiguously is often easier for AI to understand and cite. If your competitors express the same information more clearly, their content may be more likely to appear in AI-generated answers.

Visibility in Pharma Depends on Trust

As patients and HCPs use AI in their research, brands have a responsibility to ensure accurate, evidence-based content is easy to discover. Otherwise, misinformation or an anchoring bias can shape perceptions, preventing patients and HCPs from making informed decisions based on accurate information.

To be surfaced and cited by AI systems, your content needs to demonstrate the structural and evidential signals that models use as proxies for trustworthiness. Regulatory requirements already demand rigorous sourcing, balanced claims, accurate attribution, and clear documentation of evidence. The new challenge is ensuring that these quality standards are presented in formats that AI retrieval and generation systems can easily recognize and reference.

Importantly, this does not mean creating content for machines only. The same characteristics that help AI understand and cite content also improve the experience for human readers. When customers can quickly find answers, understand the source of information, and see that subject-matter experts are behind the content, they are more likely to engage with it and view your organization as a trusted authority.

If AI content visibility interests you, we can help. Viseven has both SEO and GEO specialists on board who stay on top of trends and can give your marketing efforts a boost. Just reach out to get started.

Find Out What AI Search Gets Right (and Wrong) About Your Brand

AI tools are already shaping how patients and HCPs discover medical information. Make sure they can recognize your expertise, retrieve your approved content, and represent your brand accurately.

Write to Viseven

Frequently Asked Questions (FAQs) 

What is the difference between AEO, GEO, and LLMO?

AEO helps AI systems retrieve your content as a direct answer to user queries. GEO increases the likelihood your brand gets cited in AI-generated responses. LLMO shapes how a model understands who you are based on what the broader web says about you.

Why does pharma need to optimize for AI search now?

Patients and HCPs are increasingly turning to LLMs for answers instead of traditional search. If your content isn’t structured to be retrieved, a competitor, misinformation, or an AI hallucination will fill that gap.

How does misinformation spread through AI search and why is it harder to counter?

AI systems can pull from virtually any well-structured source. Users now consume synthesized answers rather than reviewing multiple sources themselves, meaning inaccurate information can shape perceptions before someone ever reaches your official content.

What is the BLUF approach and why does it matter for life sciences content?

BLUF, Bottom Line Up Front, means leading with your key message before supporting context. AI systems extract the concise block at the top; human readers continue into the detail. The same content serves both audiences.

Does schema markup really make a difference?

Yes. Fewer than 13% of websites use structured data, making it a largely uncontested advantage. Applying FAQPage schema to relevant pages can increase citation rates in AI Overviews by more than 3x.

AUTHOR
Svitlana Denysenko Copywriter
Svitlana Denysenko
Copywriter
Svitlana Denysenko brings 10+ years of B2B and B2C copywriting experience, with the past two focused on life sciences content marketing. Naturally curious, she dives deep into topics and asks thoughtful, beyond-the-surface questions in expert interviews. Her writing is grounded in evidence-based research and crafted to deliver value. Yet, Svitlana’s mantra: “No one will consume the value unless the content is interesting to read.” That’s why storytelling is often on her to-do list.